Representational image

Bharat Biotech’s indigenous vaccine ‘Covaxin’ and Oxford-AstraZenca’s ‘Covishield’ vaccine was approved on Sunday by the Drugs Controller General of India for emergency use.

Although the Centre’s SOP is not in the final stage, here’s what we know so far from the documents released as of now:

  • About 30 crore people will be vaccinated in the first phase with healthcare workers of about one crore in the first run, followed by two crore frontline workers in the second run. Finally, about 26 crore people above 50 years will be vaccinated in the third run.

Also Read: COVID-19: Vaccine dry run successful in Meghalaya

  • As per the health ministry guidelines, about one crore people below 50 years and are suffering from chronic illness will be vaccinated in the first phase. The ministry will use the voter ID prepared ahead of the 2019 Lok Sabha elections for age proof.
  • Vaccination for people in the 20-30 age group will depend on the disease epidemiology and vaccine availability.
  • Only 100 people will be vaccinated per session at each site per day. This number can jump to 200 people if logistics allow. The SOP says, “One session for 100 beneficiaries. While most of the healthcare and frontline workers would be vaccinated at fixed session sites, vaccination of other high-risk populations may require outreach session sites, mobile sites and teams.”

Also Read: Sikkim: Phase 1 COVID-19 vaccine for health workers, common citizens after phase 3

  • The government of India is planning to use the digital platform system ‘COVID Vaccine Intelligence Network (Co-WIN),’ which will track vaccine users on a real-time basis for help. The app is still under development and will be available for download on all platforms. The registration on the app can be easily done using a voter ID, driving license, pension document, Aadhaar card, or passport.

Leave a comment

Leave a comment